Skip to content
Monday 17 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE
MorningWire

European business, markets and politics

FTSE 100
10,750.11
-0.21%
DAX
26,440.31
0.00%
CAC 40
8,636.80
0.00%
STOXX 50
6,539.59
0.00%
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
More
GermanyFranceBankingAIEnergyFintechPropertyCapital Markets
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
  • DE
Thursday 22 October 2020 1:13 pm  |  Updated:  Wednesday 28 April 2021 12:06 pm

Healthcare firm unveils £10 rapid Covid-19 test for back to work push

By: James Warrington

Add as a preferred source on Google

A private healthcare firm has unveiled a new low-cost Covid-19 test that it says could help get Brits back to work safely, though scientists have warned more development is needed.

The finger-prick test returns results in 10 minutes and is priced from just £10. As well as checking for a Covid-19 infection, it can detect the presence of antibodies, which indicate a previous infection.

The testing service, launched by digital health firm PocDoc, also provides an app allowing employers to track the health of their workforce.

Each test provides the individual with a unique QR code that enables HR departments to collate the status of employees and determine whether it is safe for staff members to return to the office.

The cut-price tests, which are manufactured in the UK and have a 98 per cent accuracy rate, could provide an alternative to pricey private services and government-issued tests, which can take several days to return results and have suffered from long waiting times in some parts of the country.

However, scientists raised doubts about how helpful the tests are for employers due to their focus on antibodies.

Covid-19 antibodies are not produced until between five and 15 days after an infection, while people are infective before they develop symptoms and have no antibodies at that stage.

Mike Lewis, professor of life science and innovation at the University of Birmingham, told Morning Wire that a focus on antigen tests — which show the presence of the virus itself — was crucial.

“The only way to get people back to work is an antigen test that is inexpensive, quick and can detect asymptomatic people.”

Read more

Cabenuva demonstrates superiority to daily oral therapy in adolescents living with HIV, as ViiV Healthcare highlights new long-acting injectable data at AIDS 2026

Lewis said that LAMP tests — such as those currently being trialled at Heathrow — were most likely to help the back to work push.

PocDoc said it has written to the government to ministers about a nationwide rollout of its tests and has offered to share its results data with Public Health England.

The service has already been trialled at restaurants, gyms and some offices, and the company is now in discussions with airports, airlines and live events.

“Everyone is aware of the extent of the testing problem and we believe we have found a solution — just register on the website and we will arrange to come round and test your teams,” said Steve Roest, PocDoc founder and chief executive.

“We are also encouraging the government to take up our offer to use our service and we hope that public health bodies will take up our offer to share our data to help the national effort.”

Heathrow Airport’s new tests, which will initially be offered to passengers flying to Hong Kong, cost £80 and guarantee results within one hour.

Testing has proved a key sticking point in the UK’s response to the coronavirus crisis, with the government’s test and trace programme coming under fierce scrutiny.

The prospect of a new rapid turnaround Covid-19 test would be a major boost for businesses, with Prime Minister Boris Johnson reportedly viewing an improved testing system as an alternative to a second national lockdown.

Read more

London-listed healthcare services firm hit by cyberattack

Assura has been the subject of a ferocious bidding war for nearly six months

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Business

Related Topics

  • Coronavirus
  • Future of Work

Trending Articles

  • Is the Zeekr 9X Super Hybrid the new luxury SUV to beat?

  • Grandparents fund university degrees to avoid inheritance tax net

  • Aldi boss wades into supermarket ‘price-gouging’ row

  • Brompton Bicycle sues former adviser for ‘professional negligence’

  • Revolut chatbot goes rogue by charging users to cancel subscription

More from Morning Wire

  • Cabenuva demonstrates superiority to daily oral therapy in adolescents living with HIV, as ViiV Healthcare highlights new long-acting injectable data at AIDS 2026

    Business Wire
  • London-listed healthcare services firm hit by cyberattack

    Markets
    Assura has been the subject of a ferocious bidding war for nearly six months
  • ViiV Healthcare to present phase IIIb data comparing Dovato with Biktarvy in treatment-naïve adults; alongside INSTI-powered long-acting injectable innovation at AIDS 2026

    Business Wire
  • Jobs market ‘stops moving’ as employment costs weigh on hirers

    Economics
    The recruitment industry is grappling with a slowdown in hiring among UK employers and wider macro-economic uncertainty.
  • Ari Emmanuel snaps up West End theatre group ATG for £4.5bn

    Hospitality
    Paddington Bear in a blue duffle coat and red hat on a purple background with BAFTA and EE logos
  • Will Formula 1 need to refund sponsors for cancelled Middle East races?

    Sport Business
    Max Verstappen in a Red Bull Racing cap and team shirt, looking contemplative with hands under his chin.
  • UK debt ‘hits £3 trillion’ milestone

    Economics
    Houses of Parliament in Westminster showcasing historic architecture under a clear sky, central to UK government and politics
  • Real Chemistry Launches Real Chemistry ANATOMI, an AI Ecosystem Purpose-Built for Healthcare Commercialization

    Business Wire
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • Europe
  • UK & Ireland

Business

  • Markets
  • Banking
  • Technology
  • Energy
  • Property
  • Fintech

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook